share_log

Pfizer | 4: Statement of changes in beneficial ownership of securities-Officer de Germay Alexandre

SEC announcement ·  Feb 29 06:35
Summary by Futu AI
On February 27, 2024, Pfizer Inc. (PFE) reported that Executive Vice President Alexandre de Germay was granted 74,377 shares of common stock. The transaction, which was completed on the same day, was a grant and not a purchase, indicating the shares were awarded at no cost to de Germay. Following this transaction, de Germay's direct holdings in Pfizer common stock amounted to a total of 74,377 shares. The grant is part of the company's compensation structure for its executives and is a common practice in the industry to incentivize management performance.
On February 27, 2024, Pfizer Inc. (PFE) reported that Executive Vice President Alexandre de Germay was granted 74,377 shares of common stock. The transaction, which was completed on the same day, was a grant and not a purchase, indicating the shares were awarded at no cost to de Germay. Following this transaction, de Germay's direct holdings in Pfizer common stock amounted to a total of 74,377 shares. The grant is part of the company's compensation structure for its executives and is a common practice in the industry to incentivize management performance.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.